Oxford Biomarker Services (OBS) has a number of partnerships with many of the top 10 pharmaceutical and diagnostic companies. These partnerships involve either protein biomarker discovery and/or biomarker assay development to support drug development programs and to develop novel diagnostic assays. A small representation of our on-going partnerships and projects is presented below. OBS would also be happy to provide contact information for many of our satisfied customers in order to obtain a reference on the services we provide.



OBS works with Pfizer to discover, verify, validate and construct assays for protein biomarkers in order to support drug development programs.



OBS and partners have a TSB funded project developing assays for monitoring safety biomarkers using zebrafish embryos as a high throughput screening system.




OBS and partners are working on discovering biomarkers and subsequently developing assays for the early detection of type 2 diabetes.